Effectiveness of 13-valent pneumococcal conjugate vaccine against vaccine-serotype community acquired pneumococcal diseases among children in China: A test-negative case-control study-Reference-Cited by-同舟云学术

Effectiveness of 13-valent pneumococcal conjugate vaccine against vaccine-serotype community acquired pneumococcal diseases among children in China: A test-negative case-control study

Published:2024-02 Issue:6 Volume:42 Page:1275-1282
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Xiaofei LIU,Yudan LI,Qinghui CHEN,Jiaming SHEN,Benfeng ZHENG,Youyi ZHANG,Biying WANG,Lijun YOU,Jun ZHANG,Jianmei TIAN,Lin LUAN,Xuejun SHAO,Genming ZHAO,Tao ZHANG

Funder

Shanghai Municipality Science and Technology Commission

Publisher

Elsevier BV

Reference32 articles.

1. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates;O'Brien;Lancet,2009

2. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15;Wahl;Lancet Glob Health,2018

3. Pneumococcal vaccines WHO position paper-2012-Recommendations;Publication;Vaccine,2012

4. Medicine CPMAVaIBotCP, Association. Expert consensus on immunoprophylaxis of pneumococcal disease (2020 version). Chinese Journal of Epidemiology 2020;41(12):1945-1979.

5. A public health evaluation of 13-valent pneumococcal conjugate vaccine impact on adult disease outcomes from a randomized clinical trial in the Netherlands;Gessner;Vaccine,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Respiratory Pathogens Surveillance Among Infants with Acute Respiratory Illnesses: A Prospective Cohort Study, China, 2023-2024;2024